BRAF and metastatic malignant neoplasm in the lymph nodes: Associations were further examined in patient subgroups divided according to clinicohistologic characteristics, including histologic type, tumor size, lymph node metastasis, extrathyroidal extension, BRAF (V600E) mutation and TNM staging.